vimarsana.com

Latest Breaking News On - Jiangsu provincial center - Page 1 : vimarsana.com

The Lancet Infectious Diseases: Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers, preliminary study finds

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years

Students get ready to go back to school

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.